Weidong Xiong

Zunyi, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Loss of eIF3m aggravates myocardial ischemia/reperfusion injury via enhancing nitrative damage and inhibiting glycolytic reprogramming.

Loss of eIF3m aggravates myocardial ischemia/reperfusion injury via enhancing nitrative damage and inhibiting glycolytic reprogramming.

Journal: Science bulletin

Published: January 10, 2026

YTHDC1 Mitigates Apoptosis in Bone Marrow Mesenchymal Stem Cells by Inhibiting NfƙBiα and Augmenting Cardiac Function Following Myocardial Infarction.

YTHDC1 Mitigates Apoptosis in Bone Marrow Mesenchymal Stem Cells by Inhibiting NfƙBiα and Augmenting Cardiac Function Following Myocardial Infarction.

Journal: Cell transplantation

Published: October 28, 2024

Insulin-like growth factor-2 mRNA-binding protein 2 facilitates post-ischemic angiogenesis by increasing the stability of fibroblast growth factor 2 mRNA and its protein expression.

Insulin-like growth factor-2 mRNA-binding protein 2 facilitates post-ischemic angiogenesis by increasing the stability of fibroblast growth factor 2 mRNA and its protein expression.

Journal: Heliyon

Published: May 26, 2024

SNX5-Rab11a protects against cardiac hypertrophy through regulating LRP6 membrane translocation.

SNX5-Rab11a protects against cardiac hypertrophy through regulating LRP6 membrane translocation.

Journal: Journal of molecular and cellular cardiology

Published: October 27, 2023

Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay.

Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay.

Journal: Journal of molecular and cellular cardiology

Published: September 20, 2023

Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets.

Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets.

Journal: Signal transduction and targeted therapy

Published: July 10, 2023

Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease.

Semaphorin3A Exacerbates Cardiac Microvascular Rarefaction in Pressure Overload-Induced Heart Disease.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 20, 2022

Methyltransferase like 3-mediated N6-methylatidin methylation inhibits vascular smooth muscle cells phenotype switching via promoting phosphatidylinositol 3-kinase mRNA decay.

Methyltransferase like 3-mediated N6-methylatidin methylation inhibits vascular smooth muscle cells phenotype switching via promoting phosphatidylinositol 3-kinase mRNA decay.

Journal: Frontiers in cardiovascular medicine

Published: April 05, 2022

Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment.

Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment.

Journal: Biomaterials

Published: May 09, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026